![]()
|
Report Date : |
07.01.2012 |
IDENTIFICATION DETAILS
|
Name : |
PUNJAB CHEMICALS AND CROP PROTECTION LIMITED (w.e.f. 16.11.2004) |
|
|
|
|
Formerly Known
As : |
PUNJAB CHEMICALS AND PHARMACEUTICALS LIMITED |
|
|
|
|
Registered
Office : |
S.C.O. 417-418, Sector – 35 – C, Chandigarh – 160022 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
19.11.1975 |
|
|
|
|
Com. Reg. No.: |
53-003603 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs.71.900 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
L24231CH1975PLC003603 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
PTLA10391D |
|
|
|
|
Legal Form : |
A Public Limited Liability company. The company’s Share are Listed on
the Stock Exchange. |
|
|
|
|
Line of Business
: |
Manufacturer of Chemicals like Oxalic Acid, Diethyl Oxalate and Sodium
Nitrite, etc. |
|
|
|
|
No. of Employees
: |
1102 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (50) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 2800000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an old and well established company having satisfactory track.
Profitability of the company is under pressure. However, Networth of the
company appears to be satisfactory. Trade relations are reported as fair.
Business is active. Payments are reported to be usually correct and as per
commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
S.C.O. 417-418, Sector – 35 – C, Chandigarh – 160022, India |
|
Tel. No.: |
91-172-2600955 /
2603120 / 2604127 |
|
Fax No.: |
91-172-2603621 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate Office : |
Plot No.: 645-646, 4th/5th Floor, Oberoi Chambers II, New Link Road,
Andheri (West), Mumbai - 400 053,
Maharashtra, India |
|
Tel. No.: |
91-22-2674 7900 (30 lines) |
|
Fax No.: |
91-22-2673 6193 /
78 / 26736013 |
|
E-Mail : |
|
|
|
|
|
Factory 1 : |
Agro-Chemicals Division Milestone-18,
Ambala Kalka Road, P.O.Bhankharpur, District SAS Nagar, Mohali -
140201, Punjab, India |
|
Tel. No.: |
91-1762-280086/280094/522253 |
|
Fax No.: |
91-1762-280070 |
|
|
|
|
Factory 2 : |
Industrial
Chemical Division – U nit Excel Phospho Chem Excel
PhosphoChem, Site No. I and II, H.A. Limited., Compound Pimpri, Pune-400 018,
Maharashtra, India |
|
Tel. No.: |
91-20-27425647-9 |
|
Fax No.: |
91-20-27425652 |
|
|
|
|
Factory 3 : |
Sulphur
Formulation Division D-2, M I D C,
Lote Parshuram,Chiplun, Taluka: Khed, District Ratnagiri - 415722, Maharashtra, India |
|
Tel. No.: |
91-2356-272240-47 |
|
Fax No.: |
91-2356-272341 |
|
|
|
|
Factory 4 : |
Pharma Division
– Unit Alpha Drug Villages: Kolimajra
and Samalheri, P.O.: Lalru, District SAS Nagar Mohali (Punjab), India |
|
Tel. No.: |
91-1762-275519/506996 |
|
Fax No.: |
91-1762-275308/506999 |
|
|
|
|
Factory 5 : |
Industrial
Chemicals Division – Tarapur E-51, M I D C Industrial
Area, Tarapur, Boisar, District Thane, Maharashtra, India |
|
Tel. No.: |
91-2525-274664-65 |
|
Fax No.: |
91-2525-272590 |
|
|
|
|
Factory 6 : |
Agro Formulation
Division, Vadodara 801, B-Tower, Alkapuri
Arca der, R.C. Dutt Road, Vadodara -390005, Gujarat, India |
|
Tel. No.: |
91-265-2353990/ 2333896 |
|
Fax No.: |
91-265-2840227 |
|
|
|
|
Branches : |
Located at : ·
Ahmedabad ·
Hyderabad ·
New Delhi |
DIRECTORS
As on 31.03.2011
|
Name : |
Mr. G. Narayana |
|
Designation : |
Chairman |
|
|
|
|
Name : |
Mr. Shalil Shroff |
|
Designation : |
Managing Director |
|
Qualification
: |
B. Com. |
|
Date of
Appointment : |
15.01.1992 |
|
|
|
|
Name : |
Mr. Atul G.
Shroff |
|
Designation : |
Director (upto
11.02.2011) |
|
|
|
|
Name : |
Mr. Vijay Rai |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Mukesh D.
Patel |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Jagdish R.
Naik |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Ajit R
Sanghvi |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Jai Parkash Bhambhani |
|
Designation : |
Director |
|
|
|
|
Name : |
Capt. S.S. Chopra (Retd.) |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Shiv Shanker
Tiwari |
|
Designation : |
Whole Time
Director |
|
|
|
|
Name : |
Mr. Rupam Shroff |
|
Designation : |
Whole Time
Director |
|
|
|
|
Name : |
Mr Avtar Singh |
|
Designation : |
Director (Operations and Business
Development) |
|
|
|
|
Name : |
Mr. R. W. Khanna |
|
Designation : |
Nominee Director (w.e.f. 30.05.2011) |
KEY EXECUTIVES
|
Name : |
Mr. Punil K. Abrol |
|
Designation : |
Senior Vice
President (Finance) and Secretary |
|
|
|
|
Name : |
Mr. Vipul Joshi |
|
Designation : |
Chief Financial Officer |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2011
|
Category of Shareholders |
No.
of Shares |
Percentage
of Holding |
|
(A) Shareholding of Promoter and Promoter Group |
|
|
|
|
|
|
|
|
1052390 |
14.49 |
|
|
2602295 |
35.83 |
|
|
3654685 |
50.32 |
|
|
|
|
|
|
2500 |
0.03 |
|
|
2500 |
0.03 |
|
Total shareholding of Promoter and Promoter Group (A) |
3657185 |
50.36 |
|
(B) Public Shareholding |
|
|
|
|
|
|
|
|
6913 |
0.10 |
|
|
1079 |
0.01 |
|
|
122027 |
1.68 |
|
|
464976 |
6.40 |
|
|
9413 |
0.13 |
|
|
604408 |
8.32 |
|
|
|
|
|
|
587678 |
8.09 |
|
|
|
|
|
|
2019168 |
27.80 |
|
|
301034 |
4.15 |
|
|
92712 |
1.28 |
|
|
14596 |
0.20 |
|
Directors
and their Relatives and Friends |
78116 |
1.08 |
|
|
3000592 |
41.32 |
|
Total Public shareholding (B) |
3605000 |
49.64 |
|
Total (A)+(B) |
7262185 |
100.00 |
|
(C) Shares held by Custodians and against which Depository
Receipts have been issued |
-- |
-- |
|
|
-- |
-- |
|
|
-- |
-- |
|
Total (A)+(B)+(C) |
7262185 |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Chemicals like Oxalic Acid, Diethyl Oxalate and Sodium
Nitrite, etc. |
||||||||
|
|
|
||||||||
|
Products : |
|
PRODUCTION STATUS AS ON 31.03.2011
|
Particulars |
Unit |
Licensed
Capacity |
Installed
Capacity |
Actual
Production |
|
Oxalic Acid and Other Oxalates |
MT |
23600 |
15850 |
10817 |
|
Agro Chemicals and their intermediaries |
MT |
11320 |
7365 |
5166 |
|
Specialty Chemicals |
MT |
1755 |
2354 |
1399 |
|
Phosphorous based compounds* |
MT |
-- |
16200 |
8908 |
|
Organic Phosphates* |
MT |
-- |
2712 |
337 |
|
Inorganic Phosphates* |
MT |
-- |
3120 |
1001 |
|
Bulk Drug* |
MT |
-- |
360 |
150 |
|
Other Chemicals |
MT |
8600 |
3500 |
1544 |
|
Sulphur based Compound* |
MT |
-- |
12750 |
8203 |
|
|
KL |
-- |
300 |
103 |
|
Formulated Goods |
Nos. |
-- |
-- |
1062085 |
|
|
MT |
5400 |
5400 |
183 |
|
|
KL |
3800 |
3800 |
397 |
|
By-Products |
MT |
11035 |
-- |
12509 |
Notes:
1. Installed Capacity is as certified by the Management on which the
auditors have relied.
2. Production includes 12,918 MT (Previous Year: 6,644 MT) quantities
produced for internal consumption.
3. *Licensed Capacity is not applicable.
4. Closing Stock are after adjustments for in-transit, damages,
shortages and sample issues.
GENERAL INFORMATION
|
No. of Employees : |
1102 (Approximately) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
·
State Bank of India ·
Bank of Baroda ·
Export-Import Bank of India ·
Allahabad Bank ·
Union Bank of India ·
Central Bank of India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
Notes : 1 Under restructuring arrangement with the Allahabad Bank cash credit
of Rs 500.000 Millions has been converted into Term Loan of Rs. 500.000
Millions (Previous Year: Rs. 500.300 as a Cash credit facility) and is
secured by way of first pari passu charge on the fixed assets (Except
Pharmaceutical division) and second pari passu charge on the current assets of the company. 2 Term Loan from Export - Import Bank of India amounting to Rs.
206.700 Millions (Previous Year : Rs.232.500 Millions) is secured by first
pari passu charge on the entire fixed assets of the Company both present and
future, second pari passu charge on current assets of the company, Corporate
guarantee from S D Agchem, Belgium, personal guarantees by two directors, and by
pledge of promoter's share in the name of Mr .Shalil Shroff held in the
Company which is in the process of execution. 3 Further, under restructuring arrangement with Export - Import Bank
of India, cash credit of Rs. 157.800 Millions (Previous year Rs. 157.800
Millions as cash credit) has been converted into working capital long term
loan. The same is secured by first pari passu charge on the entire fixed
assets of the Company both present and future, second pari passu charge on
current assets of the company both current and future, personal guarantees by
two directors, and by pledge of promoter's share in the name of Mr. Shalil
Shroff held in the Company which is in the process of execution. 4 Under restructuring arrangement with Central Bank of India Short
Term Loan is converted into Medium Term Loan amounting to Rs.247.300 Millions
(Previous Year : 250.000 Millions) and is secured by way of collateral first
pari passu charge on fixed assets of the company and second pari passu charge
on the current assets of the Company and also by personal guarantees of one
of the director. 5 Under restructuring arrangement with ICICI Bank Limited, Short Term
Loan is converted into Medium Term Loan amounting to Rs.114.700 Millions
(Previous Year: 129.900 Millions) and is secured by subservient charge on
fixed assets and current assets of the Company. 6 The company has entered into an consortium agreement with State Bank
of India (SBI) as lead bank, EXIM Bank, Bank of Baroda and Union Bank of
India for cash credit and working capital demand loan. Under consortium
agreement, cash credit and working capital facilities are secured by way of
Hypothecation of entire Current Assets present and future on a pari passu
basis with other members of the Consortium and collateral second charge on
the movable fixed assets situated at Derabassi and Lalru in the state of
Punjab, MIDC-Tarapur, Pimpari-Pune, Lote Parshuram-Chiplun in the state of
Maharashtra. 7 Credit limits of Rs. 697.300 Millions (Previous Year : Rs.492.300
Millions) with State Bank of India are secured under above consortium
agreement. Further, under restructuring, SBI has taken over term loan of Rs
609 Millions availed from HDFC Bank Limited and AXIS Bank and converted into
working capital demand loan. Also Term loan of Rs. 5.600 Millions (Previous year Rs Nil) from SBI is
secured under above consortium agreement. 8 Under restructuring arrangement with Union Bank of India, Cash
credit has been converted into Cash credit and working capital demand loan of
Rs. 1,65.200 Millions (Previous Year : Rs. 247.300 Millions) and Rs. 89.200
Millions (Previous year : Rs. Nil) respectively and is secured by security
provided under consortium agreement as mentioned above in additional to
specific charge for working capital demand loan on Pharma division located in
Lalru. 9 Under restructuring arrangement with Export-Import Bank of India
Cash credit has been converted into Cash credit and working capital demand
loan of Rs.145.000 Millions (Previous Year : Rs. 145.000 Millions) and is
secured by personal guarantees of two directors, and by pledge of promoter's
share in the name of Mr. Shalil Shroff held in the Company which is in the
process of execution, in addition to security provided under consortium
agreement as mentioned above. 10 Under restructuring arrangement with Bank of Baroda packing credit
has been converted into working capital demand loan of Rs. 270.500 Millions
(Previous year Rs 305.300 Millions as packing credit) and is secured by way
of first charge on Pharma division located in Lalru and second charge on
stock, book debts and fixed assets of the company in addition to security
given under consortium agreement. Further, Cash credit of Rs. 463.000
Millions (previous year Rs. 426.500 Millions) is secured by security given
under consortium agreement. 11 Cash credit from Indian Overseas Bank of Rs. 34.800 Millions
(Previous Year Rs. Nil) is secured by Hypothecation of plant and machineries,
stock and book debts and pledge of factory building and office premises of
Parul Division in Vadodara. 12 Loans from HDFC Bank Limited under Vehicle Finance Schemes
amounting to Rs.1.800 Millions (Previous Year : Rs. 5.600 Millions) are
secured by a exclusive charge by way of hypothecation of vehicles under the
said Schemes. 13 Loan from Housing Development Finance Corporation Limited for
Rs.3.800 Millions (Previous Year : Rs.4.600 Millions) is secured by equitable
mortgage by way of the deposit of the title deeds of the properties of
respective employees who have availed the loan under said Schemes. 14 Loan from Kotak Mahindra Prime Limited under Vehicle Finance Scheme
amounting to Rs. 6.300 Millions (Previous Year : 10.300 Millions) is secured
by a exclusive charge by way of hypothecation of vehicle under said Scheme. 15 Loan from TATA Capital Limited under Vehicle Finance Scheme
amounting to Rs.0.100 Millions (Previous Year : Rs. 0.300 Million ) is
secured by exclusive charge by way of hypothecation of vehicles purchased
under the said Scheme. 16 The finance lease obligation of Rs.5.400 Millions (Previous Year :
Rs.7.400 Millions) is secured by the plant and machinery taken under said
lease. 17 Housing Loan form ICICI Bank Limited amounting to Rs. 8.300
Millions (Previous Year : Rs. 9.800 Millions) is secured by a first charge by
way of mortgage of residential flat situated at Mumbai. |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
S. R. Batliboi and Company Chartered Accountants |
|
Address : |
5th Floor, Block B-2, |
|
Tel. No.: |
91-22-67498000 |
|
Fax No.: |
91-22-67498200 |
|
|
|
|
Subsidiaries of
the Company : |
·
STS Chemicals (UK) Limited ·
S D Agchem (Europe) NV ·
Sintesis Quimica.S.A.I.C., Argentina ·
Agrichem B.V. ·
S D Agchem (Netherlands) B.V. ·
Parul Chemicals Limited ·
Agrichem Polska SP. Z.O.O., Poland ·
N.V. Agricultural Chemicals, Belgium ·
Agrichem Helvetia GmbH, Switzerland |
|
|
|
|
Enterprises over
which key management personnel and their relatives have significant influence
: |
·
Eftec Shroff (India) Limited ·
Hemsil Trading and Manufacturing Private Limited ·
Chinmaya Metachem ·
Shalil Meta Chem |
|
|
|
|
Joint Venture
Company : |
Stellar Marine Paints Limited |
CAPITAL STRUCTURE
After 30.09.2011
Authorised Capital
: Rs.180.000 Millions
Issued, Subscribed
and Paid-up Capital : Rs.72.622 Millions
As on 31.03.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
17800000 |
Equity Shares |
Rs.10/- each |
Rs.178.000 Millions |
|
20000 |
9.8% Redeemable Cumulative Preference Shares |
Rs.100/- each |
Rs.2.000 Millions |
|
|
Total |
|
Rs.180.000
Millions |
Issued :
|
No. of Shares |
Type |
Value |
Amount |
|
7207925 |
Equity Shares |
Rs.10/- each |
Rs.72.100
Millions |
|
|
|
|
|
Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
7192892 |
Equity Shares |
Rs.10/- each |
Rs.71.900
Millions |
|
|
|
|
|
Notes:
Of the above
shares:
1) 2155662 Equity
Shares of Rs.10/- have been allotted as fully paid up by way of Bonus Shares
out of General Reserve.
2) 2281568 Equity
shares of Rs.10/- each fully paid-up have been allotted pursuant to a Scheme of
Arrangement, without payments being received in cash.
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
71.900 |
71.900 |
65.900 |
|
|
2] Equity Share Suspense Account |
0.700 |
0.000 |
20.500 |
|
|
3] Reserves & Surplus |
638.400 |
682.100 |
1005.700 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
711.000 |
754.000 |
1092.100 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
3170.500 |
2986.400 |
2137.800 |
|
|
2] Unsecured Loans |
161.600 |
246.800 |
419.600 |
|
|
TOTAL BORROWING |
3332.100 |
3233.200 |
2557.400 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
145.700 |
|
|
|
|
|
|
|
|
TOTAL |
4043.100 |
3987.200 |
3795.200 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
2481.600 |
1470.300 |
1063.000 |
|
|
Capital work-in-progress |
94.000 |
110.400 |
394.300 |
|
|
|
|
|
|
|
|
INVESTMENT |
389.100 |
452.100 |
401.200 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
531.700
|
698.000
|
756.800 |
|
|
Sundry Debtors |
1200.600
|
1354.300
|
1780.300 |
|
|
Cash & Bank Balances |
97.900
|
206.800
|
110.800 |
|
|
Other Current Assets |
29.600
|
56.000
|
41.400 |
|
|
Loans & Advances |
472.500
|
776.400
|
400.100 |
|
Total
Current Assets |
2332.300
|
3091.500
|
3089.400 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
893.800
|
702.200
|
803.400 |
|
|
Other Current Liabilities |
282.000
|
365.300
|
291.000 |
|
|
Provisions |
78.100
|
69.600
|
63.500 |
|
Total
Current Liabilities |
1253.900
|
1137.100
|
1157.900 |
|
|
Net Current Assets |
1078.400
|
1954.400
|
1931.500 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
5.200 |
|
|
|
|
|
|
|
|
TOTAL |
4043.100 |
3987.200 |
3795.200 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
3414.900 |
3026.800 |
4607.100 |
|
|
|
Other Income from Operations |
159.000 |
132.200 |
278.300 |
|
|
|
Other Income |
111.700 |
88.300 |
83.900 |
|
|
|
Exceptional Income |
61.900 |
0.000 |
0.000 |
|
|
|
TOTAL (A) |
3747.500 |
3247.300 |
4969.300 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Materials |
2335.100 |
2104.500 |
3182.700 |
|
|
|
Personnel Expenses |
180.200 |
325.000 |
286.600 |
|
|
|
Operating and Other Expenses |
1000.600 |
818.500 |
947.000 |
|
|
|
Prior Period Adjustments |
0.000 |
0.000 |
15.300 |
|
|
|
TOTAL (B) |
3515.900 |
3248.000 |
4431.600 |
|
|
|
|
|
|
|
|
Less |
PROFIT/
(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
231.600 |
(0.700) |
537.700 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
297.600 |
443.400 |
344.900 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX, DEPRECIATION AND
AMORTISATION (C-D) (E) |
(66.000) |
(444.100) |
192.800 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
69.400 |
105.900 |
91.900 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX (E-F) (G) |
(135.400) |
(550.000) |
100.900 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
0.100 |
(961.200) |
48.600 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX (G-H) (I) |
(135.300) |
(411.200) |
52.300 |
|
|
|
|
|
|
|
|
|
|
POST MERGER LOSS
OF PARUL CHEMICAL LIMITED FOR THE YEAR ENDED MARCH 31, 2010 |
(2.800) |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
0.000 |
122.600 |
101.900 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATION |
|
|
|
|
|
|
|
Proposed Dividend |
0.000 |
0.000 |
9.900 |
|
|
|
Tax on Dividend |
0.000 |
0.000 |
1.700 |
|
|
|
Transfer to General Reserve |
0.000 |
0.000 |
20.000 |
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
(138.100) |
(288.600) |
122.600 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export of Goods (FOB basis) |
1463.700 |
1071.900 |
1483.800 |
|
|
|
Commission Earnings |
0.200 |
0.000 |
0.000 |
|
|
|
Other Earnings |
45.700 |
107.000 |
37.400 |
|
|
TOTAL EARNINGS |
1509.600 |
1178.900 |
1521.200 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
736.900 |
710.200 |
940.900 |
|
|
|
Stores & Spares |
0.100 |
0.700 |
4.000 |
|
|
|
Capital Goods |
0.200 |
0.000 |
0.000 |
|
|
|
Others |
26.900 |
187.100 |
245.400 |
|
|
TOTAL IMPORTS |
764.100 |
898.000 |
1190.300 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
(18.64) |
(58.95) |
7.93 |
|
QUARTERLY RESULTS
|
PARTICULARS |
|
30.06.2011 (1st
Quarter) |
30.09.2011 (2nd
Quarter) |
|
|
|
UnAudited |
UnAudited |
|
Net Sales |
|
826.700 |
976.100 |
|
Total Expenditure |
|
802.700 |
903.300 |
|
PBIDT (Excl OI) |
|
24.000 |
66.800 |
|
Other Income |
|
13.100 |
12.200 |
|
Operating Profit |
|
37.100 |
79.000 |
|
Interest |
|
130.600 |
148.500 |
|
Exceptional Items |
|
0.000 |
0.000 |
|
PBDT |
|
(93.500) |
(69.500) |
|
Depreciation |
|
32.300 |
31.800 |
|
Profit Before Tax |
|
(125.800) |
(101.300) |
|
Tax |
|
0.000 |
0.000 |
|
Provisions and contingencies |
|
0.000 |
0.000 |
|
Profit After Tax |
|
(125.800) |
(101.300) |
|
Extraordinary Items |
|
0.000 |
0.000 |
|
Prior Period Expenses |
|
0.000 |
0.000 |
|
Other Adjustments |
|
0.000 |
0.000 |
|
Net Profit |
|
(125.800) |
(101.300) |
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
3.61
|
12.66 |
1.05 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
(3.96)
|
(18.17) |
2.19 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(2.81)
|
(12.05) |
2.43 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(0.19)
|
(0.73) |
0.09 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
6.45
|
5.79 |
3.40 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.86
|
2.72 |
2.67 |
LOCAL AGENCY FURTHER INFORMATION
OPERATIONS
The total income of the Indian operations of
the Company increased to Rs.3680.000 Millions with a net loss of Rs. 130.000
Millions in the year against the total income of Rs. 3250.000 Millions and a
net loss of Rs. 410.000 Millions in the previous year. The exports increased by
36% and were recorded at Rs. 1460.000 Millions against Rs. 1070.000 Millions in
the previous year. It may be observed that operations of the Company had
improved marginally in the year but not upto the level it should have been. The
after effects of the global meltdown, disruption of operations in the Agro
Chemicals Division due to fire and gestation period after repair of the plant
caused shortage of working capital. The high interest cost of the existing
debts further affected the working. There could be no infusion of capital from
the market as envisaged due to various
reasons.
The operations of the overseas subsidiary
companies have improved and accordingly, the consolidated income of the Company
during the year was at Rs. 6800.000 Millions against Rs. 5830.000 Millions in
the previous year with 17% increase. Accordingly, the overall loss of the
Company on consolidated basis reduced to Rs. 60.000 Millions against loss of
Rs. 590.000 Millions in the previous year.
The working of Agrichem B.V., a subsidiary
Company, has improved with new product mix resulting to a higher gross margin.
The Company added new customers for its products and obtained few new
registrations in the European countries. The Company is now able to compete in
the Crop Protection industry with its efforts, knowledge of clients and leading
products. During the year, the sales of this subsidiary Company was Rs.1780.000
Millions against Rs. 1450.000 Millions and PAT of Rs. 60.000 Millions against
the loss of Rs. 130.000 Millions in the previous year, after providing
amortization of Registration expenses.
In Sintesis Quimica, Argentina, another
subsidiary Company, the income has increased to Rs. 169 Millions from Rs.
1210.000 Millions in the year with a PAT of Rs. 31.800 Millions against Rs.
37.300 Millions in the previous year. However, the profit did not increase in
proportion to increase in sales due to enormous increase in the cost of labour
and high inflation in that country.
OUTLOOK
The Company has the facilities of
manufacturing technicals and branded formulations of agro chemicals business.
In addition, Pharma, Industrial Chemicals and specialized bio-products add to
the business prospects.
The Company has the potentials, zeal to grow,
employees' dedication and market of the products. The only constraint is high
debt and less capacity utilization due to working capital shortage. The efforts
are continued for infusion of Capital in the system to reduce pressure of the
debts. The synergy of utilization of product registrations in India and
Overseas, mixed product portfolio and efficiency in the manufacturing processes
are the key factors to bring turnaround in the Company. The integration of
products manufacturing in Indian units with the overseas registrations will add
value, once the production capacity is fully utilized.
Therefore, the outlook of the Company in the
medium to long term is growth oriented barring unforeseen circumstances.
MANAGEMENT DISCUSSION AND ANALYSIS
Business Segment - Agro Chemicals and Other Chemicals
(a) Industry Structure and Development:
The year 2010-11 has been a classic year of
economic recovery for India. The Indian economy remained on the path of rapid
resurgence which began in 2009-10. As per the Advance Estimates released by
CSO, the Indian economy has achieved a growth in real GDP of 8.6% in 2010-11
against 8% in 2009-10 and 6.08% in 2008-09. The robust industrial growth and
fiscal consolidation have brought the economy under strain from the high
inflation. Inflation peaked around March and April 2010 and has since been on a
downward trend despite a disturbing turnaround in December 2010. The food
inflation had remained high even more than last year. Last year the main
drivers of food inflation were pulses, cereals and sugar which could be
attributed to monsoon deficiency, whereas this year inflation seems to be
driven by demand factors despite higher supply levels. In one of the report
issued by Universal Ecological Fund, by 2020, considering the impacts of
climate change and population growth, global wheat production will experience a
14% deficit between production and demand; global rice production an 11%
deficit and a 9% deficit in maize production. Therefore, increasing agriculture
production and productivity is a necessary condition for ensuring national food
security, livelihood security, and nutritional security. In view of the above,
use of agrochemicals has become the necessity of the farmers to save crops to
increase the productivity. Further, growing varieties of various pests,
diseases and their growing resistance to various pesticides will keep the
demand for new products of agrochemicals upbeat.
(b) Opportunities and Threats:
The Company has the forward looking approach
and clear vision. The manufacturing of various technical agrochemicals
supported with various formulations are the right combination to grow.
The investment in obtaining various
registrations and acquisition of strategic Companies in the Latin America and
Europe are the added advantage and have strengthened the Company's presence in
the Global Agrochemical Industry. The results of Sintesis Quimica, Argentina
are encouraging. It has increased its presence in the local and international
biological market. Agrichem B.V, another subsidiary Company, is currently
exporting to over 15 countries and aims to capture the market in Africa and
Middle East. The significant investment in the Product registrations will
enable launching of several products in the coming years.
The area of operations of the domestic
formulated agro-chemical products was restricted due to shortage of working
capital. The growth potential is immense in Herbicides and Fungicides segment
on which the Company has focus. In developed countries, environment friendly
herbicides are preferred and their requirement is consistently growing whereas
the use of insecticides is declining. The new biological agro products segment
from an overseas subsidiary will add value to the business.
Liquidity, high cost of debt, longer period of
debt realisation, registration process, frequent replacement of the agro
chemicals and the international situation are few of the threats to the
Company's business. The risks are controlled by the management as adequately as
possible.
(c) Performance and outlook:
The Company is engaged in business of
manufacturing of various Agro-technicals, Agro-formulations, API's,
Pharmaceutical Intermediates, Phosphorous Derivatives and Specialty Chemicals.
It is a matter of concern that inspite of available opportunities, the Company
could not utilise full capacity due to constraint of working capital after the
global meltdown and fire in one of the Agro Chemicals unit in Punjab in April,
2009. The Company could only run operations with limited resources in the year
. There was no infusion of capital from the market as envisaged inspite of the
best efforts. During the year, the Company had requested the banks for
harmonization of their terms and restructure the loans and other working
capital facilities. The banks have accepted the same. The restructuring of
loans will enable the Company to have more moratorium for repayment and
reduction in interest.
The capacity utilisation in the plants have
shown an increasing trend inspite of various hiccups. The Working Capital
shortage delayed the running of the Agrochemicals plant in full swing. However,
it is a matter of satisfaction that the customers have cooperated with the
Company by lifting the material as per the availability.
The manufacturing of agrochemicals, speciality
chemicals, phosphorous based compounds and formulated agro chemicals remain the
major area of operations. The quality and service provided by the Company have
helped to retain all the customers.
Business Segment – Pharma
(a) Industry Structure and Development:
According to one of the reports released by
IMS Health, the global pharmaceutical market is expected to rebound in 2011
with 5% to 7 % growth in the coming year, as compared to 4% to 5% in 2010.
India's pharmaceutical industry is third
largest in the world in terms of volume and stands 14th in terms of value. It
is set to grow rapidly in the next few years as global patents of billions of
dollars worth of drugs will expire in the near future, setting the stage for
spurt in exports especially in the area of generic drugs.
The Company entered into a pharma business in
2003 after acquisition of the erstwhile Alpha Drug India Limited (ADIL), now
merged in the Company. The division is growing and had started manufacturing
another API. The number of products have increased. The CRAM business in the
division is giving good return and helps in full utilisation of the
infrastructure.
(b) Opportunities and Threats:
The international pharmaceutical market is
highly competitive. The launching of new products and Research and Development
are the key factors of success of any pharma unit. The manufacturing of fine
chemicals, API and the contract manufacturing require highest standards and
conformity to the procedures and specifications prescribed by the Principal.
(c) Performance and Outlook:
The Pharma Division of the Company has
improved working by adding new products. The pharma plant has a GMP
certification from the State Government. It has C.O.S. (Certificate of
Suitability) for the European market for its key product - Trimethoprim. It
also has ISO 9001:2000 and ISO 14001: 2004 Certificates. DNV approval of Fami
QS has opened European market for food additives, being manufactured by the
Company.
During the year, this division has been
inspected and approved for the supply of Trimethoprim and Albendazole to
European Market by European Directorate for the Quality of Medicines and
Healthcare. The division has also obtained GMP certificate from Danish
Medicines Agency, Denmark.
Subsidiaries /Acquisition/Joint Venture
The Company has merged its 70% owned
subsidiary Company, Parul Chemicals Limited during the year. SD Agrichem
(Europe) NV is the wholly owned overseas subsidiary of the Company. SD Agrichem
Netherlands B.V. and Sintesis Quimica, S.A.I.C. are the wholly owned subsidiary
companies of SD Agrichem(Europe) NV. SD Agrichem Netherlands B.V, further has a
subsidiary named Agrichem B.V. which also has three subsidiaries and
accordingly all these companies become subsidiary companies of Punjab Chemicals
and Crop Protection Limited. The Company's list of subsidiary therefore,
includes (i)STS Chemicals (UK) Limited., (ii)SD AgChem (Europe) NV,
(iii)Sintesis Quimica, Argentina, S.A.I.C. (iv)Agrichem B.V., Netherlands,
(v)N.V. Agricultural Chemicals, (vi)Agrichem Helvetia GmbH, (vii) Agrichem,
Polska., Poland and (viii)SD Agchem Netherlands, 1B.V., USA. Nedab APS, Denmark
and Kapchem Limited, Ireland were the joint ventures of the erstwhile 'Pegevo'
and now known as Agrichem, B.V. and the same have also become the Joint
Ventures of the Company.
Financial Performance and Analysis
During the year , the net sales of the Company
increased from Rs. 3030.000 Millions to Rs. 3410.000 Millions. The net loss decreased
to Rs. 130.000 Millions against Rs. 410.000 Millions in the previous year,
after adjusting certain expenses from Business Reconstruction Reserve Account.
The exports increased by 36% to Rs. 1460.000 Millions against Rs. 1070.000
Millions in the previous year.
Amalgamation of Parul Chemicals Limited with the Company
The scheme of arrangement ("the
Scheme") pursuant to section 391 to 394 read with section 78 and 100 to
103 of the Companies Act, 1956, for financial restructuring of the Company and
amalgamation of the erstwhile Parul Chemicals Limited (PCL) (hereinafter
referred to as 'Transferor Company') with Punjab Chemicals and Crop Protection
Limited (PCCPL) (hereinafter referred to as 'Transferee Company'), approved by
the members at a court convened meeting of PCCPL and as approved by the members
of PCL, was subsequently sanctioned by the Hon'ble High Courts of Punjab and
Haryana at Chandigarh and High Courts of Gujarat at Ahmedabad vide orders dated
11th March, 2011 and 23rd March, 2011 respectively. Consequently upon the
aforesaid approval, the assets and liabilities of PCL have been transferred to
and vested in the Company with retrospective effect from April 01, 2009 (the
Appointed date). The Scheme has accordingly been given effect to in these
accounts.
UNAUDITED
STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED 31.09.2011
(Rs. In Millions)
|
Particulars |
30.09.2011 Quarter
Ended (Unaudited) |
30.09.2011 Half
Year Ended (Unaudited) |
|
Sales |
975.000 |
1779.300 |
|
Excise Duty |
59.300 |
96.200 |
|
1. Net
Sales / Income from Operations |
915.700 |
1683.100 |
|
2. Other Operating Income |
60.400 |
119.700 |
|
Total Income
(1+2) |
976.100 |
1802.800 |
|
Expenditure |
|
|
|
1. (Increase)/decrease in Stock in Trade |
55.100 |
32.500 |
|
2. Consumption of Raw Materials(Including project bought outs) |
526.300 |
999.500 |
|
3. Purchase of traded goods |
47.600 |
106.600 |
|
4. Personnel Cost |
94.700 |
190.400 |
|
5. Depreciation |
31.800 |
64.100 |
|
6. Other Expenditure |
185.600 |
383.100 |
|
Total
Expenditure |
941.100 |
1776.200 |
|
Profit / (Loss)
From Operations before other Income Interest and Exceptional Items |
35.000 |
26.600 |
|
Other Income |
12.200 |
25.300 |
|
Profit/(Loss)
before Interest and Exceptional items |
47.200 |
51.900 |
|
Interest |
148.500 |
279.100 |
|
Profit / (Loss)
after interest before Exceptional items |
(101.300) |
(227.200) |
|
Exceptional Items |
0.000 |
0.000 |
|
Profit / (Loss)
From Ordinary activities before Tax |
(101.300) |
(227.200) |
|
Current and Differed Tax |
0.000 |
0.000 |
|
Net
Profit/(Loss) From Ordinary activities after Tax |
(101.300) |
(227.200) |
|
Extraordinary Items |
0.000 |
0.000 |
|
Net
Profit/(Loss) for the period |
(101.300) |
(227.200) |
|
Paid Up Equity Share Capital ( Face Value of the share Rs.10/- each ) |
72.600 |
72.600 |
|
Reserves (Excluding Revaluation Reserves) |
0.000 |
0.000 |
|
Earning / loss
per share |
|
|
|
-Basic |
(13.95) |
(31.29) |
|
-Diluted |
(13.95) |
(31.29) |
|
Public Share
Holding |
|
|
|
- Number of Shares |
3605000 |
3605000 |
|
- Percentage of shareholding |
49.64 |
49.64 |
|
Promoters and
Promoter group share holding |
|
|
|
a) Pledged / Encumbered |
|
|
|
- Number of Shares |
150000 |
150000 |
|
- Percentage of share (as a % of the total shareholding of promoter
and promoter group) |
4.10 |
4.10 |
|
- Percentage of shares(as a % of the total share capital of the
company) |
2.07 |
2.07 |
|
b) Non-encumbered |
|
|
|
- Number of Shares |
3507185 |
3507185 |
|
- Percentage of Share (as a % of the total shareholding of promoter
and promoter group) |
95.90 |
95.90 |
|
- Percentage of Share (as a % of the total share capital of the
company) |
48.29 |
48.29 |
STATEMENT
OF ASSETS AND LIABILITIES
(Rs.
in Millions)
|
Particulars |
30.09.2011 |
30.09.2011 |
|
|
|
(Unaudited) |
||
|
Shareholders Funds |
|
|
|
|
Capital |
72.600 |
71.900 |
|
|
Reserves and Surplus |
411.100 |
498.700 |
|
|
Loan Funds |
|
|
|
|
Secured |
3245.100 |
3182.000 |
|
|
Unsecured |
176.400 |
216.900 |
|
|
Deferred Tax Liabilities |
0.000 |
0.000 |
|
|
Total |
3905.200 |
3969.500 |
|
|
Fixed Assets |
2534.600 |
1572.500 |
|
|
Investment |
388.800 |
416.900 |
|
|
Current Assets, Loans and Advances |
|
|
|
|
Inventories |
495.500 |
611.800 |
|
|
Sundry Debtors |
1400.900 |
1536.700 |
|
|
Cash and Bank Balances |
65.100 |
193.800 |
|
|
Other Current Assets |
44.700 |
37.000 |
|
|
Loans and Advances |
484.600 |
793.300 |
|
|
Less : CURRENT
LIABILITIES and PROVISIONS |
|
|
|
|
Liabilities |
1420.000 |
1117.000 |
|
|
Provisions |
89.000 |
75.500 |
|
|
Net Current Assets |
981.800 |
1980.100 |
|
|
Total |
3905.200 |
3969.500 |
|
Contingent Liabilities not provided for (As on 31.03.2011):
Bills of Exchange
discounted - Rs.32.400 Millions
ii) Claims against
the Company not acknowledged as debts :
- Excise duty
matters in dispute or under appeal – Rs.14.900
Millions
- Income Tax
matters in dispute or under appeal – Rs.6.100
Millions
- Demand raised by
Sales Tax Authorities – Rs.1.100
Millions
- Labour laws
matters in dispute or under appeal – Rs.0.900 Million
- Demand raised by
previous land owners – Rs.32.700
Millions
- Other Claims –
Rs.0.600 Million
iii) Counter
Guarantees given to Banks – Rs.32.800
Millions
iv) Corporate
Guarantee given on behalf of Subsidiary Companies – Rs.832.400 Millions
(Guarantee given
in foreign currency are revalued at closing exchange rates)
[Includes
Corporate Guarantee given to State Bank of India of Rs.44.600 Millions which is
also secured by a first charge on the entire fixed assets (including immovable
property) of the company]
FIXED ASSETS
·
Freehold Land
·
Leasehold Land
·
Buildings
·
Plant and Machinery
·
Electric Installations
·
Furniture, Fixtures and Equipments
·
Vehicles
·
Computer Software
·
Computer License
·
Product Registration
BUSINESS DESCRIPTION
Subject is engaged in business of agro chemical and is manufacturing in technical grade and formulating pesticides, herbicides, fungicides and biocides. It has presence in both the domestic and international markets. The company operates in two business segments: agro chemicals and other chemicals, and Pharma. The Company’s products included oxalic acid, diethyl oxalate and sodium nitrite. During the fiscal year ended, December 31, 2011, the Company has merged its 70% owned subsidiary Company, Parul Chemicals Limited. Its subsidiaries include SD Agrichem Netherlands B.V., Sintesis Quimica, S.A.I.C., STS Chemicals (UK) Limited, SD AgChem (Europe) NV, Sintesis Quimica, Argentina, S.A.I.C., N.V. Agricultural Chemicals, Agrichem Helvetia GmbH, Agrichem, Polska., Poland and SD Agchem Netherlands, 1B.V., USA. Nedab APS, Denmark and Kapchem Limited. For the fiscal year ended 31 March 2010, Subject's revenues decreased 22% to RS5.83B. Net loss totaled RS587.9M, up from RS9.2M. Revenues reflect a reduction in income from chemicals business segment. Higher loss also reflects an increase in personnel cost, a rise depreciation and amortization charges, higher interest and other financial charges and increased stores and spares consumed.
BOARD OF DIRECTORS
Gattu Narayana (Non-Executive Independent
Chairman of the Board)
Shri. G. Narayana is Non-Executive Independent Chairman of the Board of Subject. He has experience in Engineering, Operations, General Management, Corate Management and Management of Synergy of Group Companies. His qualifications include Graduation in Electrical and Electronics Engineering and Post Graduate in Management Studies. His other Directorship include Yash Paper Mills Limited, Aryan Paper Mills Limited, Laopala R G Glass Limited, Excel Industries Limited, and a mentor to Mahavir Groupof Enterprises. He is a Corporate and Business Contributor, a path making Author, Trainer and Spiritual' Teacher, effective Counselor, committed Peace Contributor, inspiring leader, loving mentor having insightful exponent of Gita, Yoga and other spiritual paths of the world. He has an experience of more than 45 years in the Engineering, Operations, General Management, Corporate Management and Management of synergy of Group Companies. His learning includes a study of Vedas, Gita, the Upanishads, the Dhamma Pada and Indian Philosophy, Indian Ethos, Meditation, Tao, and Zen. He is the author of several path-making master pieces. He has translated "Bhagavad Geeta" (Song Supreme) into Telugu and English Poetry and written Several articles on Upanishads. "Naitiami Bharata Mata" is a song of India visualised by Narayana. His "e-books" include "ABCD for Children1, "ABCD for Youth", "ABCDfor Adults" and ABCDfor Elders". In October, 2004 he received the prestigious "International Spirit at Work Award" on behalf of Excel, where he contributed for spirituality in Board, Management and Work. He is in association with Ramakrishna Mission, Ahmedabad Management Association, Chinmaya Mission, Symbiosis and Baroda Management Association. Visited several countries on Business, Educational and Spiritual Missions.
S. S. Chopra (Non-Executive Non-Independent
Director)
Captain
(Retired) S. S. Chopra is Non-Executive Non-Independent Director of Subject. He
has experience of organization capabilities. He has served in Indian Air Force
for 15 years arid Air India for 26 years. He served as a Commissioned Officer
in the I.A.F.-from 1961 to 1976 as a pilot and took part in three wars i.e.
1962,1965 and 1971. He served as an Examiner and instructor and was also a
member of the Air Crew Examining Board. He served in Air India as a pilot from'
1976 to 2002. He is on the Board of the Company since 18.8.2004. He is not a
member of any committee in any Company.
R. W. Khanna (Director - Nominee of
Export-Import Bank of India)
Shri.
R. W. Khanna is Director - Nominee of Export-Import Bank of India of Subject.
He is a Chief General Manager of EXIM Bank.
Jagdish R. Naik (Non-Executive
Non-Independent Director)
Shri.
Jagdish R. Naik is Non-Executive Non-Independent Director of Subject. He is
Chartered Accountant. He was a partner in a reputed firm of Chartered
Accountants of M/s S.V. Ghatalia and Associates for about nine years from 1983
to 1992. Presently, he advises many companies on corporate matters including
Amalgamation, Demerger, Joint Ventures, Business Valuation, Income Tax and
Company Law matters. He has been rendering services as Corporate Advisor to
Excel Industries Limited, Transpek Silox Industry Limited and Shah Granites
Group of Companies. He is also a director in several companies including Excel
Crop Care Limited, Acrysil Limited, Anshul Specialty Molecules Limited, Agrocel
Industries Limited, Excel Industries (Europe) N.V., Excel Industries
(Australia) Ply. Limited, and Excel Genetics Limited. He is a member of the
Audit Committee and Shareholders/Investors Grievance Committee of Excel Crop
Care Limited.
Mukesh D. Patel (Non-Executive Independent
Director)
Shri.
Mukesh D. Patel is Non-Executive Independent Director of Subject. He is a
graduate in Chemical Engineering. Besides having over 36 years experience in
various areas of finance and corporate management at Director level. He had
been active in various industry related trade associations like ICMA.
CHEMEXCIL. He is also associated with trade related associations. At present he
is on the Board of Transpek Finance Limited, Universal Esters Limited, Infinity
Consultants Limited, Torrential Investment Private Limited, Shilchar Electronic
Limited, Gujarat Automotive Gears Limited, Transpek lndustry Limited and Banco
Products (lndia) Limited.
Vijay Rai (Non-Executive Independent Director)
Shri.
Vijay Rai is Non-Executive Independent Director of Subject. He is a B. Tech
from IIT Kharagpur and further done courses in marketing and personnel
management. He has over forty years experience in Industry out of which 28
years was with the industrial group in India "the Tata group". He has
worked in 12 different industries with the group such as food processing,
engineering, chemicals and fertilisers. He was the CEO for over 12 years of
Rallis India Limited(Rallis), the = Agrochemicals Company in India at that
time. He was responsible for the growth of Rallis from Rs. 25.0000 Millions to
over Rs. 120.000 Millions in ten years. He was awarded in 1999 the "Most
Admired Manager" in the Industry by the Pesticide Formulators and Manufacturers
Association. He is also on the Board of English India Clays Limited, Navneet
Publications (India) Limited, Greaves Cotton Limited, Greaves Leasing Finance
Limited, TechPak Industries Limited (Nairobi, Kenya), Polygel Industries
Private Limited, Viswas Business Synergies Limited, Prince Ware International
Private Limited, Akola Chemicals (India) Limited and Sri Biotech Laboratories
Limited. He is also the Chairman of Audit Committee of English Indian Clays
Limited and a member in the Audit and Shareholders/Investors Grievance
Committee of Greaves Cotton Limited.
Shalil S. Shroff (Chief Executive Officer,
Managing Director, Executive Director)
Shri. Shalil S. Shroff is Chief Executive Officer, Managing Director, Executive Director of Subject. His Qualifications include Management Diploma from the University of Deopage - USA. and B.Com. He is associated with the Company since 1992. He started working at the operational level and reached the position of the Managing Director after passing through various stages. He was appointed as the Executive Director with effect from 15th January, 1998, appointed as the Managing Director from 15.01.2003 to 14.01.2006 and further re-appointed from 15.01 2006 to 14.01.2009. He is on the Board of Eftec Shroff (India) Limited, Hem-Sil Trading and Manufacturing Private Limited, STS Chemicals (UK) Limited, SD Agchem (Europe) NV, Sintesis Quimica, Stellar Marine Paints -Limited and Agrichem B.V.
Avtar Singh (Director - Operations and
Business Development, Non-Independent Whole Time Director)
Shri. Avtar Singh is Director - Operations and Business Development, Non-Independent Whole Time Director of Subject. He holds B.Sc. and has over 27 years of experience. He also served in Gharda Chemicals (Private) Limited, as Jr. Chemist.
Shiv Shanker Tiwari (Non-Independent
Whole-Time Director)
Shri. Shiv Shanker Tiwari is Non-Independent Whole-Time Director of Subject. He is M.Sc and Diploma in Business Management and has over 33 years of experience. He was associated with the erstwhile STS Chemicals Limited (now amalgamated with the Company) since last 30 years and was the Whole-time Director for around 10 years. He has worked at the operational level and look after the domestic market of various chemicals and also manage production sites located in Maharashtra.
PRESS RELEASES
Punjab Chemicals and Crop Protection's director
resigns
India, November 12 -- Punjab Chemicals and Crop Protection has informed that Ajit R. Sanghvi, director (non executive) has resigned from the directorship of the company. The Board in its meeting held on November 08, 2011 has accepted his resignation with immediate effect. The above information is part of the company's filing submitted to the BSE.
Resignation of Directors
India, August 11 -- Punjab Chemicals and Crop Protection Limited has informed BSE that Shri J. H. Bhambhani Director (Non Executive) and Mrs. Rupam S. Shroff, Whole time Director have resigned from the Directorship of the Company. The Board in its meeting held on August 11, 2011 have accepted their resignation with immediate effect.
Revised Financial Results for June 30, 2011
India, August 11 -- Punjab Chemicals and Crop Protection Limited has informed BSE about the Revised Financial Results for the period ended June 30, 2011.
Appointment of Nominee
Director
India, June 23 -- Punjab Chemicals and Crop Protection Limited has informed BSE that the Export- Import Bank of India (EXIM), banker of the Company, has appointed Shri R. W. Khanna, Chief General Manager of EXIM Bank, as its Nominee Director on the Board of the Company.
PCCPL gets HC approval for scheme of amalgamation
India, May 06 -- Punjab Chemicals and Crop Protection (PCCPL) has received an approval for the scheme of amalgamation of Parul Chemicals (PCL) with itself from High Court of Punjab and Haryana at Chandigarh and High Court of Gujarat at Ahmedabad vide orders dated March 11, 2011 and March 23, 2011 respectively. The company has filed Form 21 with the Registrar of Companies (ROC) Gujarat on March 25, 2011 and with ROC Chandigarh on March 26, 2011 for submission of Court orders. The company has further informed that, the effective date of amalgamation is March 26, 2011. However, the appointed date shall remain as April 01, 2009. Further, the company will soon begin the process of issuing of equity shares to the shareholders of PCL as per the exchange ratio approved by the High Courts. PCCPL is engaged in the manufacturing of agrochemicals, pharmaceutical intermediates, APIs, phosphorous derivatives and specialty chemicals.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.78 |
|
|
1 |
Rs.81.79 |
|
Euro |
1 |
Rs.67.46 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
YES |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
50 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.